ריבלסוס 14 מ"ג - Rybelsus 14 mg

{{

× ×ª×× × ×ª×¨××¤×

××¦××ª

××××¨××

××××¢ × ××¡×£

×¡×¨××× ××

××¨×¦×××ª

××××¨××

××¦×¤××× ×××××¢ ×××¨×× ××¨××¤××× ××© ××××× ×¡ ×××©××× ×. ×× ××× × ×¨×©×× ××× ×¡ ×××¨×©×× ××¨××¤××× ××× ×©× ××§×¦××¢××ª ×¨×¤×××××.

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×§×××¦× ×¤×¨××§××××××ª (ATC4)

A10BJ
Glucagon-like peptide-1 (GLP-1) analogues

××¨××× ×¤×¢×× (ATC5)

Semaglutide 14 MG âA10BJ06

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

×××××, TABLETS
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

Rybelsus is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exerciseâ¢ as monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsâ¢ in combination with other medicinal products for the treatment of diabetes.

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

17/03/2024

××××××ª ××¡×

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª
××ª×¨××¤× ×ª×× ×ª× ××××¤×× ××××× ×¡×××¨×ª ×¡×× 2 ××¢×× ×× ×¢× ××× ××××: ×. ×¢×¨× HbA1c 7.5% ×××¢××, ×¢× BMI ××¢×¨× 28 ×××¢××, ××××¨ ×××¦×× ××××¤×× ××ª×¨××¤×ª× ××©×ª× ×ª×¨××¤××ª ×¤×××××ª, ××× ××¤×××ª, ×××©×¨ ×× ×¡××× ××¢××¨ ××¤× ×§×¨××××××¡. ×. ×¢×¨× HbA1c 7.5% ×××¢××, ×¢× BMI ××¢×¨× 25 ×××¢××, ×××××× ×××× ×××××× â ××××ª ×× ××××××ª, ×××× ×¡×¨××¨×××¡×§×××¨××ª, ××××ª ×××× ××¨×× ××ª, ××××ª ××× ×× ×¤×¨××¤×¨××ª - (PVD - Peripheral vascular disease), ××××¨ ×××¦×× ××××¤×× ××ª×¨××¤×ª× ××ª×¨××¤× ×¤××××ª ×××ª ××× ××¤×××ª, ×××©×¨ ×× ×¡××× ××¢××¨ ××¤× ×§×¨××××××¡. ×. ×¢×¨× Hb1ac ××× 7.0-7.5%, ×¢× BMI ××¢×¨× 25 ×××¢××, ×××××× ×××× ×××××× - ××××ª ×× ××××××ª, ×××× ×¡×¨××¨×××¡×§×××¨××ª, ××××ª ×××× ××¨×× ××ª, ××××ª ××× ×× ×¤×¨××¤×¨××ª - (PVD - Peripheral vascular disease), ××××¨ ×××¦×× ××××¤×× ××ª×¨××¤×ª× ××©×ª× ×ª×¨××¤××ª ×¤×××××ª ××× ××¤×××ª, ×××©×¨ ×× ×¡××× ××¢××¨ ××¤× ×§×¨××××××¡.	19/02/2025	×× ×××§×¨×× ××××××	LIRAGLUTIDE, LIXISENATIDE, DULAGLUTIDE, SEMAGLUTIDE, EXENATIDE	×¡×××¨×ª ×¡×× 2, Diabetes
××ª×¨××¤× ×ª×× ×ª× ××××¤×× ××××× ×¡×××¨×ª ×¡×× 2 ××¢×× ×× ×¢× ×× ×××: ×. ×¢×¨× HbA1c 7.5% ×××¢×× ××¢×× ×× ×¢× ××× ××××: 1. ×¢× BMI ××¢×¨× 28 ×××¢××; 2. ×¢× BMI ××¢×¨× 25 ×××¢××, ×××××× ×××× ×××××× â ××××ª ×× ××××××ª, ×××× ×¡×¨××¨×××¡×§×××¨××ª, ××××ª ×××× ××¨×× ××ª, ××××ª ××× ×× ×¤×¨××¤×¨××ª - (PVD - Peripheral vascular disease). ×. ×× ×¡××× ××¢××¨ ××¤× ×§×¨××××××¡; ×. ××××¨ ×××¦×× ××××¤×× ××ª×¨××¤×ª× ××©×ª× ×ª×¨××¤××ª ×¤×××××ª, ××× ××¤×××ª.	17/03/2024	×× ×××§×¨×× ××××××	LIRAGLUTIDE, LIXISENATIDE, DULAGLUTIDE, SEMAGLUTIDE, EXENATIDE	×¡×××¨×ª ×¡×× 2, Diabetes

××¡××¨×ª ××××× ××¡×

××ª×¨××¤× ×ª×× ×ª× ××××¤×× ××××× ×¡×××¨×ª ×¡×× 2 ××¢×× ×× ×¢× ××× ××××:

×¢×¨× HbA1c ×©× 7.5% ×××¢×× ×¢× BMI ××¢×¨× 28 ×××¢××, ××××¨ ×××¦×× ××××¤×× ××ª×¨××¤×ª× ××©×ª× ×ª×¨××¤××ª ×¤×××××ª, ××× ××¤×××ª, ×××©×¨ ×× ×¡××× ××¢××¨ ××¤× ×§×¨××××××¡
×¢×¨× HbAlc ×©× ×××¢×× ×¢× BMI ××¢×¨× 25 ×××¢××, ×××××× ×××× ×××××× - ××××ª ×× ××××××ª, ×××× ×¡×¨××¨×××¡×§×××¨××ª, ××××ª ×××× ××¨×× ××ª, ××××ª ××× ×× ×¤×¨××¤×¨××ª - PVD â(Peripheral vascular disease), ××××¨ ×××¦×× ××××¤×× ××ª×¨××¤×ª× ××ª×¨××¤× ×¤××××ª ×××ª, ××× ××¤×××ª, ×××©×¨ ×× ×¡××× ××¢××¨ ××¤× ×§×¨××××××¡
×¢×¨× HbA1c ××× 7.0-7.5%, ×¢× BMI ××¢×¨× 25 ×××¢××, ×××××× ×××× ×××××× - ××××ª ×× ××××××ª, ×××× ×¡×¨××¨×××¡×§×××¨××ª, ××××ª ×××× ××¨×× ××ª, ××××ª ××× ×× ×¤×¨××¤×¨××ª - PVD â(Peripheral vascular disease), ××××¨ ×××¦×× ××××¤×× ××ª×¨××¤×ª× ××©×ª× ×ª×¨××¤××ª ×¤×××××ª ××× ××¤×××ª, ×××©×¨ ×× ×¡××× ××¢××¨ ××¤× ×§×¨××××××¡

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 15.08.2022

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 15.08.2022 ×¢××× ××¦×¨×× ×× ××××ª Patient information leaflet â15.08.2022 ×¢××× ××¦×¨×× ×¢×¨×××ª ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 15.08.2022

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×¨××××¡××¡ 14 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	NOVO NORDISK A/S, DENMARK
×©× ××¢× ××¨××©××	NOVO NORDISK LTD., ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 5/2020. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	11/05/2023

×ª××× ×ª ××¨×××

×ª××× ×ª ××¨×××

השינוי האחרון נעשה בֹ־1 בנובמבר 2025 ב־04:18

ריבלסוס 14 מ"ג - Rybelsus 14 mg

ויקיתרופות